Sumatriptan
Product Images NDC 33261-663

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 33261-663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sumatriptan Usp 1)

Chemical structure diagram of Sumatriptan showing its molecular framework, including an indole ring with a sulfonamide group, side chains, and carboxyl groups.*

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Usp 2)

Line chart depicting the estimated probability of response over time in minutes from the initial dose for Sumatriptan doses of 25 mg, 50 mg, 100 mg, and placebo. The graph shows increasing response probabilities over a 240-minute period, with higher doses generally associated with higher response rates.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Usp 3)

A line graph depicting the estimated probability of remediation or rescue over time in hours from the initial dose for placebo and Sumatriptan doses of 25 mg, 50 mg, and 100 mg. The x-axis shows time in hours up to 24 hours, and the y-axis shows probability up to 100%. Four lines represent the different groups, showing increasing probability over time.*

FDA Label Image

Image Description (Sumatriptan Usp 4)

Sumatriptan USP 50 mg tablet packaging label by Aidarex Pharmaceuticals LLC. The label shows a white oblong tablet with imprint 'C' on one side and '33' on reverse. It indicates 9 tablets per pack, generic for Imitrex, manufactured by Aurobindo Pharma Ltd. India, with NDC 33261-0663-01. The label includes dosage instructions and multiple peel-off tabs with product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.